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ABSTRACT
miRNAs play key roles in the nervous system,
where they mark distinct developmental stages.
Accordingly, dysregulation of miRNA expression
may have profound effects on neuronal physiology
and pathology, including cancer. Among the
neuronal miRNAs, miR-9 was shown to be
upregulated during in vitro neuronal differentiation
and downregulated in 50% of primary neuro-
blastoma tumors, suggesting a potential function
as an oncosuppressor gene. In this study we
characterized the promoter and the transcriptional
regulation of the miR-9-2 gene during neuronal dif-
ferentiation. We found that, despite its localization
inside an exon of a putative host-gene, miR-9-2 is
expressed as an independent unit with the promoter
located in the upstream intron. By promoter fu-
sion and mutational analyses, together with RNAi
and Chromatin immunoprecipitation assays, we
demonstrated that the concerted action of the
master transcriptional factors RE1-silencing
transcription factor (REST) and cAMP-response
element binding protein (CREB) on miR-9-2
promoter induces miRNA expression during differ-
entiation. We showed that the repressor REST
inhibits the activity of the miR-9-2 promoter in undif-
ferentiated neuroblastoma cells, whereas REST dis-
missal and phosphorylation of CREB trigger
transcription in differentiating cells. Finally, a regu-
latory feed-back mechanism, in which the reciprocal
action of miR-9 and REST may be relevant for the
maintenance of the neuronal differentiation
program, is shown.
INTRODUCTION
The mammalian nervous system is the anatomic district
including the highest cellular diversity, with each cell type
displaying a speciﬁc gene expression proﬁle that dy-
namically changes in response to synaptic activity. Such
ﬂexibility requires a highly orchestrated coordination of
gene expression programs, which is achieved through
integrated levels of gene regulation at all stages of
neuronal development.
A signiﬁcant portion of such regulation is provided by
microRNAs, ‘ﬁne-tuning’ modulators of gene expression
at the post-transcriptional level (1) that, through their
pleiotropic action, have a relevant role in neuronal devel-
opment as well as in maintenance and plasticity of neural
connections (2).
Mammalian miRNA genes are organized either in gene
clusters, which are transcribed in a coordinate manner
from a single polycistronic transcription unit, or as
monocistronic genes (3). Such genomic assortment is
further complicated by intronic and exonic localization.
About 62% of miRNAs are located within the introns
of either non-protein-coding or protein-coding transcrip-
tion units, whereas only 10% are encoded inside exons.
A further 27% displays intergenic organization (4,5).
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is a spatio-temporal regulated process (6,7). Notably,
miRNA mis-expression is often associated with human
diseases, such as cancer (8,9), making relevant the study
of the mechanisms governing their expression.
Evidence is emerging for the importance of post-
transcriptional control of miRNAs (10); nevertheless, tran-
scriptional control,which isthe major level of regulation, is
still poorly understood, since only a handful of miRNA
promoters have been functionally characterized (11).
In this article, we present structural and functional char-
acterization of the promoter region of the human miR-9-2
gene, encoding for an evolutionary conserved miRNA,
expressed almost exclusively in the brain (12,13). miR-9
has been implicated in nervous system development, physi-
ology and pathology in several organisms (14,15). We
recently highlighted its property as an onco-suppressor
miRNA, with a crucial role in repressing cell proliferation
of human neuroblastoma and medulloblastoma cell lines
(16,17).
We demonstrate that the transcription of the miR-9-2
gene, which displays an unusual exonic localization, is in-
dependent from that of its host gene, whereas it is directed
by a previously unidentiﬁed promoter.
We identify a relevant function for the transcription
factors RE1-silencing transcription factor (REST) and
cAMP-response element binding protein (CREB) in
controlling miR-9-2 gene expression. The repressor REST
is crucial for maintaining low levels of miR-9-2 in undiffer-
entiated cells, whereas REST dismissal and simultaneous
phosphorylation of the already bound neuronal activator
CREB trigger miR-9-2 transcription, ensuring high levels
of miR-9 during in vitro neuronal differentiation.
Finally, our data directly demonstrates the existence
of a feedback mechanism in which the reciprocal action
of miR-9 and REST, previously described as one of the
miR-9 targets (18), may be responsible for the mainten-
ance of the neuronal differentiation program.
MATERIALS AND METHODS
Cell cultures and treatments
SK-N-BE cells were cultured in RPMI medium 1640
(Gibco, Carlsbad, CA, USA), supplemented with 10%
fetal bovine serum (EU Standard, South American
Origin, Gibco), 1  L-glutamine, and penicillin/strepto-
mycin, and induced to differentiation by 10mM all-trans-
RA (Sigma-Aldrich, St Louis, MO, USA). Plasmids,
siRNAs and LNA oligonucleotides were transfected into
SK-N-BE cells by Lipofectamine and Plus Reagent
(Invitrogen, Carlsbad, CA, USA).
RNA extraction and cDNA synthesis
Total RNA was extracted from conﬂuent plates of un-
treated or RA-treated SK-N-BE cells, using TRIzol
(Invitrogen) as recommended by the manufacturer’s
protocol. Prior to cDNA synthesis, 5mg of RNA
samples were treated with 1U of DNase (Promega,
Madison, WI, USA). cDNA was generated using
SuperScript III (Invitrogen).
Rapid ampliﬁcation of 5’ complementary DNA ends
(50RACE)
miR-9-2 Transcriptional Start Site (TSS) was mapped
by 50RACE System (Invitrogen). DNA-free RNA was
retro-transcribed using a speciﬁc primer (50-CTCGGCT
GTAGTCTTTCATTCTCACACGC-30) that anneals
downstream of miR-9-2 stem-loop structure; the
generated cDNA was ampliﬁed utilizing the oligonucleo-
tide 50-CCAAAGATAACAACTCGCTTCCC-30 as the
speciﬁc primer.
Primer extension
The position of the miR-9-2 TSS was further conﬁrmed
by primer extension. An amount of 20mg of DNA-free
RNA were reverse-transcribed with the g-
32P-labeled
oligonucleotide 50-CCTCTGTCTTCCTCTTGCCAGAC
TCC-30. Reaction products were fractionated by
denaturing PAGE together with the sequencing reaction,
obtained from M13 single strand DNA, by using the
SequenaseVersion 2.0 DNA SequencingKit (GE
Healthcare).
Promoter analysis
Conserved DNA fragments located upstream of miR-9-2
TSS were PCR-ampliﬁed employing the oligonucleotides
reported in Supplementary Table S1, and inserted into
pGL3-Basic vector (Promega). Single plasmids were
co-transfected into SK-N-BE cells together with the
control plasmid (pRL-TK). After 24–72h of incubation
in the presence or absence of RA, cells were assayed
with the Dual-Luciferase Assay (Promega). The CREB
mutant derivative, lacking CREB binding site, was
obtained from the wild-type construct by inverse PCR,
utilizing the primers reported in Supplementary Table S1.
Protein extraction and western blot assay
Whole-cell protein extracts were prepared from SK-N-BE
cells lysed in RIPA buffer. Extracts were separated by elec-
trophoresis on 4–12% poly-acrylamide gel (Invitrogen)
and electroblotted onto nitrocellulose membrane
(Protran, S&S, Drammen, Norway); immunoblots were
incubated overnight with polyclonal antibodies anti-
REST 07-579, anti-CREB 06-863, anti-phospho-CREB
(Ser133) 06-519 (Millipore, Billerica, MA, USA), and for
1h with monoclonal antibody against GAPDH (6C5)
sc-32233 (Santa Cruz Biotechnology, Inc.) as a loading
control.
Analysis of RNA expression by RT–PCR and
Quantitative Real Time RT–PCR
An amount of 1–5mg of DNA-free RNA were reverse-
transcribed using a mixture of poly-dT oligonucleotides
and random examers (Invitrogen). In order to quantify
the expression of miR-9 host gene transcripts, 50ng of
each generated cDNA were ampliﬁed in triplicate by
Quantitative Real Time RT–PCR (qRT–PCR), in the
presence of Power SYBR Green PCR Master Mix
(Applied Biosystems) and 3pmol of each sequence-speciﬁc
primer (Supplementary Table S2). qRT–PCR was
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Fast Real-Time PCR System (Applied Biosystems).
Thermal cycle conditions were the following: 2min at
50 C for activation and 10min of initial setup at 95 C,
followed by 40 cycles at 95 C for 15s and at 60 C for
60s. Data were calculated with 7500 Software v2.0.3
(Applied Biosystems) by the CT method and expressed
as relative quantities (RQs) after GAPDH normalization.
The same cDNA was utilized to determine pri-miR-9-1,
pri-miR-9-2 and pri-miR-9-3 expression levels through
semi-quantitative PCR (25–30 cycles at 94 C for 30s,
at 55 C for 45s and at 72 C for 30s), performed using
speciﬁc oligonucleotides listed in Supplementary Table S2.
PCR fragments were separated by 2.5% agarose gel
electrophoresis.
Analysis of REST mRNA 30UTR
RNA was reverse-transcribed as described earlier.
The 30UTR was analyzed by semi-quantitative PCR
using the oligonucleotides reported in Supplementary
Table S2. PCR fragments were separated by 2% agarose
gel electrophoresis.
Northern blot analysis
An optimized northern blot protocol for small RNA
analysis was employed. Total RNA extracted from
SK-N-BE cells was fractionated on 10% poly-acrylamide
gel in MOPS–NaOH (pH 7), 7M Urea and transferred
onto Amersham Hybond-NX nylon membrane (GE
Healthcare). RNA cross-linking was performed in
0.16M N-(3-Dimethylaminopropyl)-N0-ethylcarbodiimide
hydrochloride and 0.13M 1-methylimidazole (Sigma-
Aldrich) at pH 8, for 2h at 60 C (19). DNA oligonucleo-
tides complementary to the sequence of mature miR-9 (17)
and to 5S-rRNA (50-TGAACGCGCCCGATCTCG
TCT-30) were
32P-labeled and used as probes.
Chromatin immuno-precipitation assay
Untreated or 1day and 6 days RA-treated SK-N-BE cells,
grown to conﬂuence in 10-cm dishes, were cross-linked
with PBS in the presence of formaldehyde at a ﬁnal con-
centration of 1% at room temperature for 10min.
Chromatin immunoprecipitation (ChIP) assays were
carried out as previously described (5), with minor modi-
ﬁcations. Before immunoprecipitation, 30ml of super-
natant were saved as input (IN). Chromatins were
immunoprecipitated (IP) with 5–10mg of speciﬁc
antibodies, anti-REST 07-579, anti-CREB 06-863,
anti-phospho-CREB (Ser133) 06-519, anti-acetyl-Histone
H3 06-599 (Millipore), at 4 C overnight. No addition of
antibody was used as a negative control (NA). After
incubating 30ml of Protein A Agarose/Salmon Sperm
DNA with IP and NA samples at 4 C for 1h, beads
were sequentially washed with low-salt buffer (0.1%
SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris–HCl,
pH 8.0 and 150mM NaCl), high-salt buffer (0.1% SDS;
1% Triton X-100; 2mM EDTA, 20mM Tris–HCl, pH 8.0
and 0.5M NaCl), LiCl buffer (0.25M LiCl, 1% Nonidet
P-40, 1% sodium deoxycholate, 1mM EDTA, and 10mM
Tris–HCl, pH 8.0), and TE buffer (10mM Tris–HCl, pH
8.0 and 1mM EDTA). The DNA–protein complexes were
eluted by elution buffer (1% SDS and 0.1M sodium bi-
carbonate) at room temperature. Reverse-cross-linking
was performed by incubating the eluted DNA–protein
complexes with 300mM NaCl at 65 C overnight and
treating with Proteinase K (Roche) at 45 C for 1h.
Puriﬁed DNA fragments from IP, IN and NA samples
were ampliﬁed by multiplex semi-quantitative PCR,
employing Immolase (Bioline) in the presence of [a-
32P]-
dATP (PerkinElmer) and a mixture of speciﬁc primers,
spanning across CR599257 gene, and primers targeting
tRNA
Glu gene transcriptional unit, for the unrelated
control (Supplementary Table S3). Thermal cycle condi-
tions were: 30 cycles of 94 C for 30s, 60 C for 60s and
72 C for 40s. PCR fragments were separated by 8% poly-
acrylamide gel electrophoresis. Gels were exposed onto
Storage Phosphor Screen (GE Healthcare) and data
were collected by densitometric analysis performed with
Typhoon Trio (GE Healthcare). The speciﬁc immuno-
precipitation enrichment was calculated as the ratio
between IP and IN, after subtracting NA from IP, and
normalized versus the unrelated region (tRNA
Glu gene).
miR-9 ectopic expression
Overexpression of miR-9 was carried out by transfecting
SK-N-BE cells with a plasmid in which the miR-9 coding
region was cloned between the polII promoter and termin-
ation region of the U1 snRNA gene. As control, a plasmid
producing an unrelated 21-nt long RNA, bearing no
homology to any known miRNA or mRNA sequence in
human was employed (17). miR-9 over-expression was
assessed by northern blot analysis.
CREB and REST knock-down
CREB expression was silenced by RNAi. SK-N-BE cells
were transfected with a speciﬁc siRNA against CREB
mRNA at a ﬁnal concentration of 20nM (Hs CREB1
5 SI00299894, Qiagen) or, as control, with an unrelated
siRNA (AllStars Neg. Control siRNA, Qiagen), and
treated with RA for 3 days. The efﬁciency of CREB
knock down was evaluated by western blot analysis.
REST expression was silenced both by over-expressing
miR-9 and by RNAi. SK-N-BE cells were transfected in
absence of RA with the plasmid expressing human miR-9
(17), or with a mixture of speciﬁc siRNAs against REST
mRNA at a ﬁnal concentration of 20nM (Hs REST 1
SI00701407, Hs REST 5 SI04153765; Hs REST 7
SI04333588, Qiagen); as controls, cells were transfected
with a plasmid expressing an unrelated 21-nt long RNA
(17), or with an unrelated siRNA (AllStars Neg. Control
siRNA, Qiagen). The efﬁciency of REST knock-down was
evaluated by western blot analysis.
miR-9 knock down
FITC-labeled LNA oligonucleotide (Exiqon,Vedbaek,
Denmark) against miR-9 was transfected into SK-N-BE
cells overexpressing miR-9 at a ﬁnal concentration of
50nM.
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Expression proﬁling of miR-9 and host genes during
neuronal differentiation
According to the UCSC genome browser (http://
genome.ucsc.edu/), human miR-9 is encoded by three
distinct genomic loci, miR-9-1, miR-9-2 and miR-9-3,
generating three mature miR-9 species with identical se-
quences. These loci are located on chromosome 1, 5 and
15, respectively and each one is associated with annotated
UCSC cDNAs (Supplementary Figure S1). In particular,
miR-9-1 is located in the second intron of the C1orf61
gene encoding for the CROC4 protein, miR-9-2 is pos-
itioned in the last exon of the annotated overlapping
BC036480, AX746931 and CR599257 non-coding genes
and miR-9-3 is embedded within the ﬁrst intron of the
non coding CR612213 gene.
To correlate the expression of the putative host genes
with those of the individual miRNAs, we analyzed the
expression proﬁles of both the individual genes and the
pri-miR-9 species in proliferating versus differentiating
cells. As model system, we utilized the human
neuroblastoma-derived SK-N-BE cell line that can be
induced to neuronal differentiation by treatment with
retinoic acid (RA).
The expression proﬁle of miR-9 host genes was
analyzed by qRT–PCR, utilizing oligonucleotides speciﬁc
for putative exonic regions. In the case of miR-9-1 and
miR-9-2 host genes the oligos were selected in regions
common to all the annotated transcripts (Supplementary
Figure S1). Figure 1A shows that the expression of the
miR-9-1 host gene was high in proliferating cells and
decreased upon RA treatment; the miR-9-3 host transcript
was instead expressed both in untreated and in RA-treated
cells, whereas the miR-9-2 host transcripts were not ex-
pressed both in undifferentiated and in differentiating
cells. The identiﬁcation of the latter transcripts in NB4
cells indicated the suitability of the oligos utilized for tran-
script identiﬁcation (Supplementary Figure S2).
The analysis of pri-miR-9 species was carried out by
RT–PCR utilizing oligonucleotides matching each one
of the pri-miRNA-9 species. Figure 1B shows that
the expression of both pri-miR-9-1 and pri-miR-9-2
increased up to 6 days of RA-treatment to drop off
later; pri-miR-9-3 expression was, instead, not detectable
both in untreated and RA-treated cells. These results are
in agreement with the reported exclusive expression of
miR-9-1 and miR-9-2 in mammalian brain (20).
Altogether, these results indicate that there was no cor-
relation between the expression of pri-miR-9 species and
that of the corresponding host genes, suggesting that they
are expressed by independent pathways. In particular, we
focused our studies on miR-9-2 for its peculiar exonic
localization.
Identiﬁcation of miR-9-2 TSS
To investigate the possibility that miR-9-2 could be inde-
pendently transcribed from its host gene, its TSS was ﬁrstly
determined. Primer extension and 50RACE assays on total
RNA from RA-treated SK-N-BE cells were carried out
using primers designed to anneal the stem structure of
the pre-miRNA (Figure 2). The TSS mapped 410-nt
upstream of the 50 end of the pre-miRNA, in a pos-
ition not matching any of the UCSC reported TSS
of the miR-9-2 host transcripts. This result suggests
that miR-9-2 transcription relies on an independent
promoter.
Identiﬁcation of miR-9-2 promoter
Several histone modiﬁcations have been described as chro-
matin signatures for promoter identiﬁcation in human
cells (21–23). Among them, acetylation of histone H3
lysine 9 and 14 (H3K9,14Ac) was shown to be diagnostic
for transcriptionally active promoters (21). To identify the
promoter region driving miR-9-2 expression, we initially
investigated the H3 lysine 9 and 14 acetylation level on the
chromatin of the presumptive host gene promoter and of
the hypothetical regulative region upstream of miR-9-2
TSS.
ChIP assays using antibodies against H3K9,14Ac
were performed on untreated and 6 days RA-treated
SK-N-BE cells. The regions analyzed were selected ac-
cording to their evolutionary conservation, derived from
the UCSC genome browser. This search highlighted
three intronic highly conserved regions, spanning
 1-kb upstream of miR-9-2 TSS. As control, two
conserved regions at  100- and 700-bp upstream of
Figure 1. Expression proﬁles of miR-9 transcripts. (A) Expression proﬁling of miR-9-1, miR-9-2 and miR-9-3 host gene transcripts by qRT–PCR.
(B) Expression proﬁling of miR-9 primary transcripts (pri-miR-9) by RT–PCR. In both (A) and (B) panels, the expression levels were evaluated at
speciﬁc time-points (days, indicated below each bar) of RA treatment and normalized against GAPDH mRNA levels. White, grey and black bars
refer to miR-9-1, miR-9-2 and miR-9-3 genes, respectively. Error bars in the histograms represent the standard deviation obtained from three
independent experiments.
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Figure 3A show that acetylated H3 histone is speciﬁcally
associated with the intronic regions ( 600 and  800)
upstream of the miR-9-2 TSS after cell treatment with
RA for 6 days, whereas background interaction was
detected in the absence of RA and in the presumptive
promoter region of the host gene. These results point to
the intronic region upstream of miR-9-2 as the one
competent for miRNA transcriptional activity upon
RA-treatment.
Figure 3. Identiﬁcation of miR-9-2 promoter. (A) Analysis of histone acetylation on miR-9-2 and CR599257 gene upstream regions. ChIP assays
were performed on chromatin samples from 6 days-RA treated (black bars) or untreated (white bars) cells, immunoprecipitated with antibodies
against H3K9,14Ac. PCR-ampliﬁed regions are reported below each bar of the histogram and are indicated by double-headed arrows in the
underneath schematic representation. Immunoprecipitation levels are expressed as fold enrichment with respect to an unrelated region (tRNA
Glu).
Error bars in the histogram represent the standard deviation obtained from three independent experiments. (B) Analysis of CR599257 and miR-9-2
promoter activity by luciferase assay. The luciferase-based reporter construct ( 1090), containing the 1-kb region upstream of the miR-9-2 TSS, and
its deletion mutant derivatives thereof were tested together with the construct containing the conserved 500-bp region upstream of the CR599257
gene TSS. For each reporter construct, schematized on the left, the histogram shows luciferase expression levels, evaluated as the ratio between the
values measured in 3 days RA-treated versus untreated cells. The promoter-less reporter construct was tested as control (b). Error bars in the
histogram represent the standard deviation obtained from three independent experiments.
Figure 2. Identiﬁcation of miR-9-2 TSS by 50RACE and primer extension analyses. Left panel: the product of 50RACE (lane 1) was fractionated
along with a DNA ladder (lane M). The arrowhead points to the ampliﬁed product. Right panel: the primer extension reaction (lane 2) was run in
parallel with the sequencing reaction (lanes G, A, T and C). The arrowhead indicates the extended product. In the underneath schematic represen-
tation, the 50 end of the reported miR-9-2 host transcript (+1) is pointed out by a thin arrow. The thick arrow points to the miR-9-2 TSS; the
distance of the TSS from miR-9-2 stem loop structure is reported as nucleotide length.
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1-kb region upstream of miR-9-2 TSS to characterize the
sequences promoting miR-9-2 transcription during
neuronal differentiation. We generated a ﬁrst construct
in which the 1-kb region was cloned in a promoter-less
reporter vector, pGL3-Basic, upstream of the FLuc
reporter gene ( 1090 construct) (Figure 3B). According
to the sequence conservation data, three additional con-
structs containing shorter upstream sequences of 590, 390
and 84bp (constructs  590,  390 and  84, respectively)
were derived. As control, the most conserved 500-bp
region upstream of CR599257 gene TSS was cloned in
the same reporter vector (CR599257 construct). These
ﬁve different constructs were transfected into untreated
or RA-treated SK-N-BE cells, and Fluc activity was
measured as the ratio between the values obtained in
RA-treated versus untreated cells. Among the different
constructs, the  1090 displayed the strongest Fluc induc-
tion upon RA treatment. This result indicated that the
1-kb region is the minimal promoter triggering miR-9-2
transcription during in vitro neuronal differentiation.
Identiﬁcation of the transcription factors controlling
miR-9-2 gene expression
To identify the transcription factors involved in the regu-
lation of miR-9-2 expression, an algorithmic prediction of
potential transfactor binding sites within the identiﬁed
promoter was carried out using the Chip-Mapper Web
Server (http://mapper.chip.org/). Among the others,
putative binding sites for the neuro-restrictive silencer
factor REST and the cAMP responsive element binding
protein CREB were identiﬁed in very conserved regions
(Figure 4A). To investigate the involvement of these tran-
scription factors in miR-9-2 gene regulation during
neuronal differentiation, we ﬁrst examined their expres-
sion proﬁle in RA-treated SK-N-BE cells by western
blot (Figure 4B). We utilized antibodies against total
CREB (lanes CREB), recognizing both the unphos-
phorylated and the phosphorylated forms of the tran-
scriptional factor, and antibodies speciﬁc for the
phosphorylated form (lanes pCREB); we found no
marked modulation either for CREB and for its active
Figure 4. Association of transcriptional factors with miR-9-2 promoter chromatin. (A) Conservation of the region upstream of miR-9-2 stem loop
structure in mammals, according to UCSC genome browser. The conserved binding sites for CREB and REST are indicated by grey and white
boxes, respectively, according to the Chip-Mapper Web Server. (B) Analysis of total CREB (CREB), phospho-CREB (pCREB) and REST (REST)
protein levels. Upper panels: SK-N-BE cells were treated with RA for the times indicated above each lane and total protein extracts were analyzed by
western blot. Signals were normalized for GAPDH levels. Lower panel: densitometric analyses of western blots. Results are normalized against
GAPDH and expressed as RQs versus untreated cells (lane 0). (C) and (D) ChIP analysis of total CREB and phospho-CREB (CREB and pCREB
respectively) and REST occupancy at the miR-9-2 promoter. Chromatin samples were obtained by cells treated with RA for the times (days)
indicated below each bar. Immunoprecipitation levels are expressed as fold enrichment with respect to the tRNA
Glu gene. Error bars in the
histograms represent the standard deviation obtained from three independent experiments.
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signiﬁcantly decreased along the differentiation process.
As a second step, we examined the promoter occupancy
of the selected factors by ChIP assays (Figure 4C and D
and Supplementary Figure S3). Chromatin from untreated
and RA-treated SK-N-BE cells was immunoprecipitated
with antibodies against total CREB, pCREB, and REST.
Figure 4C shows that CREB is already bound to the
promoter region at time 0 and persists up to 6 days of
RA treatment. Notably, the association of pCREB on
the promoter region, very low in proliferating cells,
increased in RA-treated cells, reaching the highest level
at 6 days upon RA-treatment (Figure 4C). From these
results it appears that CREB is already bound to the
promoter in undifferentiated cells, but it is the
phosphorylated form that is present during differenti-
ation. The analysis of the association of the repressor
REST with the promoter region revealed that it was at
maximum level in undifferentiated cells, dropping off at
6 days upon RA-treatment (Figure 4D).
Altogether, these results indicate that pCREB and
REST are associated to the miR-9-2 promoter region
in vivo, in a differentiation-controlled fashion; in particu-
lar, with the progression of differentiation, the occupancy
of phosphorylated CREB parallels REST dismissal.
Functional analysis of CREB and REST
transcriptional regulation
To assess the functional contribution of CREB to miR-9-2
transcriptional control, a deletion mutant lacking the
CREB binding site (CREB) was derived from the
 1090 construct (Figure 5A). The wild-type  1090 con-
struct and the CREB mutant were transfected in
Figure 5. Functional analysis of transcriptional factor activities. (A) Functional analysis of CREB by luciferase assay. Cells were transfected with the
constructs, represented aside each histogram bar, and grown in the presence or in the absence of RA. Values for each construct were calculated as the
ratio of luciferase activities in 3 days RA-treated versus untreated cells, normalized against control cells transfected with the  1090 construct, and
expressed as percentage. (B) Upper panel: functional analysis of CREB by knock down experiment. Cells treated with RA for 3 days (+RA) were
transfected with siRNAs against CREB (CREB siRNA) or with an unrelated siRNA (CTRL siRNA). Results are based on qRT–PCR analysis of
pri-miR-9-2 levels. Error bars in the histograms represent the standard deviation obtained from three independent experiments. Lower panel: western
blot analysis of CREB levels in untreated (lane  RA), RA-treated (lanes +RA), and CREB-interfered cells (lane CREB siRNA). The anti-CREB
RNAi caused a 60% decrease in protein level as evaluated from three independent experiments. As control, cells transfected with an unrelated siRNA
were utilized (lane CTRL siRNA). GAPDH was employed as a loading control. (C) Left panel: western blot analysis of REST levels in untreated
(lane  ), 3 days RA-treated (lane RA), and REST-interfered cells (lane siREST). The anti-REST RNAi caused a 80% decrease in protein level as
evaluated from three independent experiments. As control, cells transfected with an unrelated siRNA were utilized (lane siCTRL). GAPDH was
employed as a loading control. Right panel: functional analysis of REST. Luciferase-based constructs, represented aside each histogram bar, were
co-transfected with an unrelated siRNA (black bars) or with siRNAs-interfering for REST expression (grey bar) in proliferating cells. Luciferase
activity was normalized against control cells transfected with the  590 construct and the control siRNA, and expressed as percentage. Error bars in
the histograms represent the standard deviation obtained from three independent experiments. In both (A) and (C) panels, the binding sites for
CREB and REST are depicted as dotted and white boxes, respectively.
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treated cells. Luciferase expression from both constructs
was evaluated as the ratio between the values observed in
RA-treated versus untreated cells. In comparison to the
wild-type, the luciferase expression from CREB con-
struct was 40% lower, suggesting that CREB is a critical
element for inducing transcriptional activation during
RA-induced differentiation (Figure 5A).
To conﬁrm this result, CREB knock down experiment
was performed in RA-treated SK-N-BE cells and
the levels of the endogenous pri-miR-9-2 evaluated.
Figure 5B shows that speciﬁc siRNA-mediated knock-
down of CREB (lower panel) resulted in a decrease of
 60% of pri-miR-9-2 level (upper panel).
To determine the role played by REST, we analyzed
luciferase expression in proliferating cells (a condition in
which REST is bound to the promoter region) from the
 590 construct, containing the three binding sites for
REST, and from the  390 construct, a deletion mutant
lacking two REST binding sites. Compared to the
expression level of the  590 construct, that from the
 390 was 70% higher (Figure 5C, right panel).
Moreover, a loss-of-function approach was carried out
and both the luciferase expression of the reporter con-
struct (-590) and the endogenous level of pri-miR-9-2 tran-
script were evaluated. siRNA-mediated knockdown of
REST resulted in upregulation of  40% of luciferase ex-
pression from  590 construct (Figure 5C), whereas the
level of the endogenous pri-miR-9-2 was unaffected
(data not shown). To verify whether the latter result
could be due to the residual REST still present on the
miR-9-2 promoter, following the siRNA-mediated
knockdown, ChIP experiment was performed in
REST-interfered cells. The results indicate that no
REST is associated to miR-9-2 promoter (Supplementary
Figure S4).
Overall, the luciferase assays demonstrate the repressor
activity of REST on the reporter gene. On the other hand,
the analysis of the endogenous transcript reveals that dis-
missal of REST is not sufﬁcient for transcriptional
activation.
Since miR-9-1 gene expression pattern was similar to
that of miR-9-2 gene during in vitro differentiation
(Figure 1B), we asked whether the REST/CREB regula-
tion was a common mechanism for the two loci.
Preliminary in silico analysis about the occurrence of
REST and CREB sites on the miR-9-1 promoter described
by Ko et al. (24), showed the presence of putative binding
sites at  130-nt and at  1232-nt upstream of miR-9-1
stem loop structure for CREB and REST, respectively.
To demonstrate the involvement of these factors in
miR-9-1 transcription, the levels of the endogenous
pri-miR-9-1 were evaluated in the cells knocked down
for REST and CREB, as described for miR-9-2 analysis.
We found that the knock down of the transcriptional ac-
tivator CREB in RA-treated cells caused a decrease of
 40% of pri-miR-9-1 levels (Supplementary Figure S5).
On the contrary, the knock down of REST in undifferen-
tiated cells did not affect pri-miR-9-1 transcription (data
not shown).
miR-9 controls REST expression during neuronal
differentiation
It was previously shown (18) that miR-9 targets REST
mRNA in HEK 293 cells and in RA-induced NT-2 cells.
Notably, miR-9, which is upregulated during RA-induced
differentiation of SK-N-BE cells (17), inversely correlates
with the amount of REST, which undergoes down-
regulation after RA treatment. This suggests that REST
expression might be modulated by miR-9 during neuronal
differentiation. To conﬁrm this hypothesis, we analyzed
in a preliminary study the 30UTR of REST mRNA
in proliferating versus differentiating SK-N-BE cells. In
fact, it has been reported that some transcripts undergo
30UTR shortening, resulting from alternative cleavage and
polyadenylation, during neuronal activation (25) or em-
bryonic development (26). Evaluation of the 30UTR of
REST mRNA was performed by RT–PCR, and revealed
that the  3.7-kb long region, containing the three binding
sites for miR-9 (18), was not altered during in vitro differ-
entiation of SK-N-BE cells (Supplementary Figure S4).
This result indicates that REST mRNA may be targeted
by miR-9 during neuronal differentiation. To validate
this hypothesis, miR-9 was overexpressed ( 10-fold) in
neuroblastoma cells (Figure 6A) and REST levels were
evaluated by western blot. Figure 6B shows that the
ectopic expression of miR-9 caused  70% decrease of
REST (lane 2). Moreover, treatment of neuroblastoma
cells overexpressing miR-9 with an anti-miR-9 LNA
oligonucleotide restored the endogenous level of REST
(Figure 6B, compare lane 4 with lane 1), further
demonstrating the speciﬁc action of miR-9 on REST
gene expression.
To correlate miR-9-dependent REST downregulation
with transcriptional induction, luciferase expression from
the  590 construct, containing the three REST binding
sites, was measured in SK-N-BE cells overexpressing
miR-9 or an unrelated 21-nt long RNA. Figure 6C
shows that miR-9 ectopic expression (grey bar) increased
of  40% luciferase expression with respect to the control
cells transfected with the same  590 construct and an un-
related 21-nt long RNA. Notably, such an induction was
comparable to that observed upon speciﬁc REST
knockdown performed by RNAi (Figure 5C).
DISCUSSION
miR-9 has been proposed as one of the crucial regulators
of neuronal development in several organisms. In
Drosophila, it is involved in cell fate speciﬁcation of de-
veloping sensory organs (12); in zebraﬁsh, it participates in
midbrain-hindbrain boundary deﬁnition (14); in mouse
cortical development, it is involved in differentiation of
Cajal Retzius cells (15). In mammals, miR-9 is induced
upon embryonic stem cell neuronal differentiation and
blocking its function during this process decreases
neuronal differentiation at the expense of astrocytes (27).
Alteration of miR-9 expression has been reported in
Alzheimer’s disease and its downregulation has been
observed in Huntington’s disease, suggesting its further
implication in neurodegeneration (18,28). We previously
6902 Nucleic Acids Research, 2010,Vol.38, No. 20showed that miR-9 is upregulated during in vitro neuronal
differentiation, whereas it is downregulated in 50% of
primary neuroblastoma (NB) tumors (17). However,
miR-9 altered expression is not genetically determined
by chromosome aberrations, since no one of the three
distinct loci encoding for human miR-9 are positioned
within the chromosomal regions rearranged in neuroblast-
omas (29,30). It transpires that miR-9 dys-regulation in
these tumors could be due to alteration in gene expression.
Analyses aimed at proﬁling the expression of the three
individual miR-9 host genes and the pri-miR-9 species, in
proliferating versus differentiating NB cells, underlined a
non correlative expression between them. This suggests
that the transcription of both the intronic and the exonic
miR-9 genes is independent from that of the host genes,
and is driven by their own promoters. Notably, this
conclusion is in accordance with the recent ﬁnding
highlighted by several research groups that, combining
bioinformatic strategies with experimental approaches,
found many intronic miRNAs, the expression of which
is controlled by upstream regulatory elements, independ-
ent of the host genes (22,31,32).
Further analyses were aimed at unveiling the transcrip-
tional regulation of miR-9-2 gene, that displays a less
common exonic localization. We showed that the TSS of
the pri-miRNA maps at 410-nt upstream of the
pre-miRNA, and that the promoter region is located in
the upstream intron, which displays histone modiﬁcations
typical for an active chromatin domain. These results
demonstrated that miR-9-2 is expressed by a transcription
unit, different from that of the host gene, depending on
a dedicated promoter, and that, therefore, miR-9-2 and
Figure 6. Feed-back regulatory loop between miR-9 and REST. (A) The ectopic expression of miR-9 was veriﬁed by northern blot (lanes 2–4) and
normalized with respect to 5S-rRNA expression. SK-N-BE cells were transfected with the plasmid overexpressing miR-9 in the absence of LNA (lane
2), or together with a control LNA (lane 3), or with the anti-miR-9 LNA (lane 4). RNA from cells transfected with the control plasmid expressing an
unrelated 21-nt long RNA was analyzed in lane 1. (B) Western blot analysis of REST protein levels. SK-N-BE cells were transfected with the plasmid
overexpressing miR-9 in the absence of LNA (lane 2), or together with a control LNA (lane 3), or with the anti-miR-9 LNA (lane 4). The
overexpression of miR-9 caused a 70% decrease in protein level (lane 2) as evaluated from three independent experiments. Proteins from cells
transfected with the control plasmid expressing an unrelated 21-nt long RNA were analyzed in lane 1. GAPDH protein levels were used as a loading
control. (C) Effect of miR-9 over-expression on REST activity. Reporter luciferase-based constructs (indicated on the left) were co-transfected with
the control plasmid expressing an unrelated 21-nt long RNA (black bars) or with the plasmid over-expressing miR-9 (grey bar) in proliferating cells.
Luciferase activity was normalized against cells transfected with the  590 construct and with the unrelated 21-nt long RNA, and expressed as
percentage. Binding sites for REST are depicted as white boxes. Error bars in the histogram represent the standard deviation obtained from three
independent experiments. (D) Minicircuitry illustrating the functional interplay between miR-9, REST and CREB. In proliferating SK-N-BE cells
(grey arrows), REST occupies miR-9-2 promoter and represses miR-9 expression at the transcriptional level. Upon RA treatment (black arrows) the
dismissal of REST and the phosphorylation of CREB, already bound to the promoter, induce miR-9 transcription, which in turn represses REST
expression, contributing to the maintenance of the differentiation program.
Nucleic Acids Research, 2010,Vol.38, No. 20 6903its putative host gene are physically overlapped but
functionally independent. Such conclusions are in line
with genome scale computational studies of intergenic
miRNA gene promoters, which claimed that putative pro-
moters of  85% of these genes reside between  500- and
 1000-bp upstream of the pre-miRNA. This implies
that real core promoters of most intergenic miRNA
genes are relatively close to the pre-miRNA structure
(33). Accordingly, we found that the region encompassing
 1-kb upstream of miR-9-2 TSS was sufﬁcient for
transcriptional induction during in vitro neuronal differ-
entiation, thus representing the miR-9-2 minimal
promoter.
Search for transcription factors involved in miR-9-2
gene regulation allowed us to highlight two antagonistic
molecules, the repressor REST and the activator CREB,
which function in an opposite and temporally regulated
manner. REST is a well known suppressor of neuronal
genes in non neuronal cells; it functions by binding to a
conserved element (RE1) in neuronal loci and recruiting
histone deacetylases by corepressors, associated with its
repressor domains (34). The downregulation of this
master regulator of neuronal genes is imperative during
neuronal differentiation to allow neuronal genes to be
expressed. On the other side, the activator CREB plays
a pivotal role in regulating a wide range of neuronal
functions, as neuronal survival, neuronal proliferation
and differentiation, and is crucial for mediating long-
term memory and synaptic plasticity (35). Furthermore,
CREB was demonstrated to regulate transcription of
miR-132, which has a crucial role in neuronal morphogen-
esis (36). It has been reported that the binding of this
factor to its target genes does not require its
phosphorylated status, whereas the crucial event in the
activator function of CREB is the phosphorylation at
Ser 133 (37). The involvement of these factors in
miR-9-2 gene expression control was previously suggested
by computational studies (38) and by experimental data
that identiﬁed a REST binding site 45-kb upstream of
miR-9-2 stem loop precursor (39). However, no functional
studies on the promoter activity of that region were per-
formed, missing the identiﬁcation of the proximal
promoter here characterized, that is instead necessary
and sufﬁcient to reconstitute miR-9-2 correct temporal
expression.
In this study, we found that in proliferating cells, where
it is highly expressed, REST is bound to the miR-9-2
promoter preventing transcriptional activity. Upon RA
treatment, REST dismissal and the concomitant phos-
phorylation of CREB, already bound to the promoter,
activate transcription. In the light of these data, we
propose that the opposite and temporally coordinated
action of these factors would ensure the low level of
miR-9 in undifferentiated cells and its induction during
differentiation. Notably, the functional analyses of the in-
volvement of REST and CREB in the transcriptional
regulation of the miR-9-1 gene, showed that miR-9-1 ex-
pression is unaffected by REST knockdown, whereas it is
impaired by CREB depletion. These results strongly
suggest that REST/CREB regulation is a common
mechanism shared by miR-9-1 and miR-9-2 loci, both
contributing to miR-9 production during neuronal
differentiation.
Noteworthy, we also demonstrated that REST mRNA
is targeted by miR-9 during in vitro neuronal differenti-
ation of SK-N-BE cells. This ﬁnding strongly supports the
earlier evidence, provided by Packer and colleagues (18),
of a regulative double negative feed-back loop between
REST and miR-9, which may contribute to the mainten-
ance of differentiation programs (Figure 6D).
In conclusion, our data add new insight into the
deﬁnition of cell-speciﬁc mechanisms underlying miRNA
biosynthesis, and support the general conclusion that a
complex network of transcription activators and repres-
sors acting together with miRNAs may be responsible for
coordinating neuronal gene expression during neuronal
development (38).
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